HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noriko Fukuhara Selected Research

K 7174

1/2013A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noriko Fukuhara Research Topics

Disease

17Neoplasms (Cancer)
09/2022 - 01/2010
12Lymphoma (Lymphomas)
05/2022 - 08/2010
8Multiple Myeloma
10/2022 - 01/2017
7Infections
08/2021 - 09/2003
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2021 - 08/2013
6B-Cell Lymphoma (Lymphoma, B Cell)
05/2022 - 01/2011
5Hematologic Neoplasms (Hematological Malignancy)
03/2021 - 03/2014
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2020 - 08/2018
5Hodgkin Disease (Hodgkin's Disease)
10/2020 - 05/2017
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2016
4Leukemia
08/2021 - 01/2019
4Disease Progression
05/2021 - 01/2016
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2021 - 01/2017
4Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020 - 04/2017
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 12/2016
3Hemorrhage
03/2022 - 11/2018
3Sideroblastic Anemia
01/2022 - 11/2014
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020 - 06/2017
3Acute Erythroblastic Leukemia (Erythroleukemia)
01/2019 - 01/2015
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2022 - 01/2020
2Pathologic Complete Response
09/2022 - 01/2010
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2022 - 11/2012
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2022 - 09/2020
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2022 - 07/2018
2X-linked sideroblastic anemia
01/2022 - 01/2013
2Pneumonia (Pneumonitis)
12/2021 - 05/2021
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2020 - 01/2018
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 08/2017
2Anemia
03/2014 - 01/2013
1Extranodal NK-T-Cell Lymphoma
10/2022
1Body Weight (Weight, Body)
05/2022
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2022
1IGA Glomerulonephritis (IGA Nephropathy)
03/2022
1Glomerulonephritis
03/2022
1Primary Myelofibrosis (Myelosclerosis)
03/2022
1Febrile Neutropenia
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Constipation
01/2022
1Plasmacytoma
10/2021
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
09/2021
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
09/2021
1Crohn Disease (Crohn's Disease)
08/2021
1Fever (Fevers)
06/2021
1Lymphopenia (Lymphocytopenia)
06/2021
1Hypoalbuminemia
06/2021

Drug/Important Bio-Agent (IBA)

15Rituximab (Mabthera)FDA Link
07/2021 - 08/2013
5Methotrexate (Mexate)FDA LinkGeneric
09/2022 - 08/2017
4Bortezomib (Velcade)FDA Link
10/2022 - 09/2011
4Brentuximab VedotinIBA
09/2022 - 05/2017
4tirabrutinibIBA
06/2022 - 05/2019
4ibrutinibIBA
08/2021 - 12/2016
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2020
4Monoclonal AntibodiesIBA
10/2020 - 01/2017
3venetoclaxIBA
01/2022 - 03/2021
3Prednisolone (Predate)FDA LinkGeneric
01/2021 - 01/2020
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2020
3Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 01/2020
3Tacrolimus (Prograf)FDA LinkGeneric
10/2020 - 08/2017
3Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2003
3CytokinesIBA
01/2016 - 01/2013
2AnthracyclinesIBA
10/2022 - 06/2018
2Azacitidine (5 Azacytidine)FDA Link
01/2022 - 05/2021
2Biomarkers (Surrogate Marker)IBA
12/2021 - 05/2019
2daratumumabIBA
10/2021 - 08/2019
2Bendamustine HydrochlorideFDA Link
07/2021 - 04/2017
2Transaminases (Aminotransferases)IBA
06/2021 - 12/2020
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
03/2021 - 01/2019
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2021 - 05/2019
2NivolumabIBA
10/2020 - 05/2017
2Alemtuzumab (Campath)FDA Link
01/2020 - 01/2017
2AcidsIBA
01/2019 - 11/2014
2PorphyrinsIBA
01/2019 - 06/2017
2MethyltransferasesIBA
10/2014 - 03/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 01/2013
1Lenalidomide (CC 5013)FDA Link
10/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2022
1Plasminogen Activators (Plasminogen Activator)IBA
06/2022
1parsaclisibIBA
05/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2022
1Reticulin (Reticular Fiber)IBA
03/2022
1Immunoglobulin A (IgA)IBA
03/2022
15-Aminolevulinate SynthetaseIBA
01/2022
1HLA-DRB1 Chains (HLA DRB1)IBA
12/2021
1RNA (Ribonucleic Acid)IBA
08/2021
1bosutinibIBA
08/2021
1glecaprevir and pibrentasvirIBA
08/2021
1Antiviral Agents (Antivirals)IBA
08/2021
1Dasatinib (BMS 354825)FDA Link
08/2021
1Infliximab (Remicade)FDA Link
08/2021
1Imatinib Mesylate (Gleevec)FDA Link
08/2021
1nilotinibFDA Link
08/2021
1polatuzumab vedotinIBA
07/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021

Therapy/Procedure

17Drug Therapy (Chemotherapy)
09/2022 - 01/2010
11Transplantation
06/2022 - 07/2011
10Hematopoietic Stem Cell Transplantation
09/2022 - 01/2010
9Therapeutics
10/2022 - 01/2011
5Stem Cell Transplantation
06/2022 - 09/2018
4Induction Chemotherapy
09/2022 - 04/2019
1Laminectomy
01/2022